Identification of key pharmacological components and targets for aidi injection in the treatment of pancreatic cancer by uplc-ms, network pharmacology, and in vivo experiments

HIGHLIGHTS

• who: Haojia Wang from the Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China have published the research work: Identification of key pharmacological components and targets for Aidi injection in the treatment of pancreatic cancer by UPLC-MS, network pharmacology, and in vivo experiments, in the Journal: (JOURNAL)
• what: The authors established a xenograft model using human pancreatic cancer cells in nude mice to investigate the anticancer effect of ADI in_vivo.
• how: For screening the following conditions applied the protein structure was obtained by X . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.